- 2020.11.17
- News Release Showa Denko Materials and the Drug Development Startup TAGCyx Sign a Commissioned Development Agreement on Regenerative Medicine Technologies
- 2020.9.18
- News Release TAGCyx announces a research collaboration with CAGE Bio Inc. for autoimmune skin diseases.
- 2020.5.5
- News Release TAGCyx raises approximately 200 million JPY
- 2020.2.19
- News Release TAGCyx and GC Pharma has entered into collaborative research and development for conducting various pre-clinical studies of TAGX-0004
- 2019.12.25
- News Release TAGCyx receives milestone payment for collaborative research with HEALIOS K.K.
- 2019.10.10
- News Release TAGCyx enters into a collaborative aptamer glycosylation research agreement with GlyTech, Inc.
- 2019.10.9
- News Release TAGCyx has executed a collaborative antibody-aptamer conjugate research agreement with Chiome Bioscience Inc.
- 2018.9.28
- News Release TAGCyx has executed collaborative research agreement with HEALIOS K.K.
- 2018.4.29
- News Release Completion of 500 million JPY Series B financing
- 2017.2.1
- News Release TAGCyx has executed a research and development collaboration agreement with a European biopharma company in February. The partnership will continue for 2 years which is extendable with mutual agreement and will apply the TAGcyx platform towards the identificatio
- 2016.8.31
- News Release TagCyx announces the completion of 500 million Japanese Yen (US$ 4.9 Million, as of Aug. 31, 2016) private financing, led by The University of Tokyo Edge Capital as a lead investor, and SMBC Venture Capital, Nissay Capital CO., LTD. (Aug 2016)
12